A Study of Homoeopathic Medicine TARAXACUM OFFICINALE with Computer Simulation and Clinical Evaluation of the same in the Management of CHRONIC URTICARIA

TARAXACUM OFFICINALE in CHRONIC URTICARIA: An In Silico Modelling and Randomized Controlled Clinical Trial In Homoeopathy - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/086491

Enrollment

Registered

2025-05-07

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L509- Urticaria, unspecified

Interventions

Intervention1: Taraxacum officinale: Taraxacum Officinale 6C in 40 sized globule 3 globule thrice a day for 5 weeks Control Intervention1: Homeopathic Constitutional Medicine: Constitutional Medicine

Eligibility

Inclusion criteria

Inclusion criteria: 1. 18 70 years of both Sex 2. Patient with increased serum IgE level. 3. Patients with symptoms of chronic urticaria

Exclusion criteria

Exclusion criteria: 1. Patients with urticarial vasculitis, angioedema. 2. Patients with serious systemic illness like malignancies, malignant hypertension, uncontrolled diabetes etc. 3. Pregnancy and Lactation 4. Immunocompromised individuals

Design outcomes

Primary

Measure	Time frame
1.In silico study TITLE : Action of phytochemical compounds on target protein after in silico study. DESCRIPTION : Identification of phytochemical compound with more binding energy on target organ. 2. Clinical study A. TITLE : Changes in Urticaria Activity Score 7 before and after treatment DESCRIPTION : Baseline UAS 7 score Final UAS 7 score B. TITLE : Reducing serum Ig E level before and after treatment DESCRIPTION : Baseline Ig E Final Ig E Timepoint: 1.In silico study INTERVAL : Minimum of 1 month 2. Clinical study 2A. UAS7 Score INERVAL : 3 weeks 2B. Serum IgE INTERVAL : 3 months	—

Measure

Time frame

1.In silico study TITLE : Action of phytochemical compounds on target protein after in silico study. DESCRIPTION : Identification of phytochemical compound with more binding energy on target organ. 2. Clinical study A. TITLE : Changes in Urticaria Activity Score 7 before and after treatment DESCRIPTION : Baseline UAS 7 score Final UAS 7 score B. TITLE : Reducing serum Ig E level before and after treatment DESCRIPTION : Baseline Ig E Final Ig E Timepoint: 1.In silico study INTERVAL : Minimum of 1 month 2. Clinical study 2A. UAS7 Score INERVAL : 3 weeks 2B. Serum IgE INTERVAL : 3 months

—

Secondary

Measure	Time frame
Comparison of Therapeutic effectiveness of Taraxacum officinale and constitutional medicine among the groupTimepoint: After 1 year ( after completion of the study )	—

Countries

India

Contacts

Public ContactDr Divya Babu

Govt Homeopathic Medical College Karaparamba Kozhikode

drjayakishan@gmail.com9446529775

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026